Company news

ClearPoint Neuro Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022

April 25, 2022

ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference

March 28, 2022

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results

February 28, 2022

ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue

February 14, 2022

ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference

January 4, 2022

ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System

November 16, 2021

ClearPoint Neuro Reports Third Quarter 2021 Results

November 8, 2021

ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients

November 7, 2021

ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference

November 3, 2021

Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors

November 1, 2021

ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021

October 25, 2021

ClearPoint Neuro Reports Second Quarter 2021 Results

August 9, 2021

ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG

August 8, 2021

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® Neuro Navigation System at Hôpital Fondation Rothschild in Paris

August 3, 2021

ClearPoint Neuro to Announce Second Quarter 2021 Results August 10, 2021

August 1, 2021

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution

July 20, 2021

ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

July 14, 2021

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland

June 15, 2021

ClearPoint Neuro Set to Join Russell 3000® Index

June 13, 2021

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease

June 7, 2021

ClearPoint Neuro to Present at the UBS Global Healthcare Virtual Conference

May 18, 2021

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software

May 17, 2021

ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’

May 10, 2021

ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room

May 9, 2021

ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021

April 28, 2021

ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

April 27, 2021

ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 22, 2021

ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.

April 12, 2021

ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease

April 5, 2021

ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel

March 23, 2021

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results

March 3, 2021

ClearPoint Neuro Announces Closing of Public Offering of 2,127,660 Shares of Common Stock

February 22, 2021

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021

February 18, 2021

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

February 17, 2021

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

February 17, 2021

ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock

February 17, 2021

ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems

February 10, 2021

ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher as Chairman of the Board of Directors

February 4, 2021

ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners

January 25, 2021

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe

January 13, 2021

ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results

January 11, 2021

ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms

December 28, 2020

ClearPoint Neuro Completes 4,000th ClearPoint® Neuro Navigation Procedure

November 29, 2020

ClearPoint Neuro Reports Third Quarter 2020 Results

November 9, 2020

ClearPoint Neuro to Announce Third Quarter 2020 Results on November 10

November 3, 2020

ClearPoint Neuro Announces Transition Plan for New Chief Financial Officer

September 13, 2020

ClearPoint Neuro Reports Second Quarter 2020 Results

August 11, 2020

ClearPoint Neuro to Announce Second Quarter 2020 Results on August 12

August 5, 2020

ClearPoint Neuro Reports First Quarter 2020 Results

May 11, 2020

ClearPoint Neuro to Announce First Quarter 2020 Results on May 12

May 6, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 61 decks. Every deck is listed under its year.